英文原著論文 Original Papers in English


緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2021 年 】(IF: 2020 年)

  1. Mishra A, Duplaà C, Vojinovic D, Suzuki H, Sargurupremraj M, Zilhão NR, Li S, Bratz TM, Jian X, Zhao W, Hofer E, Wittfeld K, Harris SE, van der Auwera-Palitschka S, Luciano M, Bis JC, Adams HHH, Satizabal CL, Gottesman RF, Gampawar PG, Bülow R, Weiss S, Yu M, Bastin ME, Lopez OL, Vernooij MW, Beiser AS, Völker U, Kacprowski T, Soumare A, Smith JA, Knopman DS, Morris Z, Zhu Y, Rotter JI, Dufouil C, Hernández MV, Maniega SMM, Lathrop M, Boerwinkle E, Schmidt R, Ihara M, Mazoyer B, Yang Q, Joutel A, Tournier-Lasserve E, Launer LJ, Deary IJ, Mosley TH, Amouyel P, DeCarli CS, Psaty BM, Tzourio C, Kardia SLR, Grabe HJ, Teumer A, van Duijn CM, Schmidt H, Wardlaw JM, Ikram MA, Fornage M, Gudnason V, Seshadri S, Matthews PM, Longstreth Jr WT, Couffinhal T, and Debette S. Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate. Brain. (in press)(IF=13.501)

  2. Evangelou E, Suzuki H, Bai W, Pazoki R, Gao H, Matthews PM, Elliott P. Alcohol consumption in the general population is associated with structural changes in multiple organ systems. eLife. 10: e65325, 2021. (IF=8.146)

  3. Tadros R, Francis C, Xu X, Vermeer AMC, Harper AR, Huurman R, Bisabu KK, Walsh R, Hoorntje ET, WP Te Rijdt, Buchan RJ, van Velzen HG, van Slegtenhorst MA, Vermeulen JM, Offerhaus JA, Bai W, de Marvao A, Lahrouchi N, Beekman L, Karper JC, Veldink JH, Kayvanpour E, Pantazis A, Baksi AJ, Whiffin N, Mazzarotto F, Sloane G, Suzuki H, Schneider-Luftman D, Elliott P, Richard P, Ader F, Villard E, Lichtner P, Meitinger T, Tanck MWT, van Tintelen JP, Thain A, McCarty D, Hegele RA, Roberts JD, Amyot J, Dubé MP, Cadrin-Tourigny J, Giraldeau G, L'Allier PL, Garceau P, Tardif JC, Boekholdt SM, Lumbers RT, Asselbergs FW, Barton PJR, Cook SA, Prasad SK, O'Regan DP, van der Velden J, Verweij KJH, Talajic M, Lettre G, Pinto YM, Meder B, Charron P, de Boer RA, Christiaans I, Michels M, Wilde AAM, Watkins H, Matthews PM, Ware JS, Bezzina CR. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nature Genetics. 53: 128–134, 2021. (IF=38.330)

  4. Kimura A, Takahama H, Nishikimi T, Takashio S, Hayashi T, Nagai-Okatani C, Nakagawa Y, Yasuda S, Anzai T, Minamino N, Izumi C. Molecular ratio of mature B-type natriuretic peptide in acute heart failure: An indicator for ventricular contractile recovery. ESC Heart Failure 2021;8: 5617–5621 (IF=4.411)

  5. Kato K, Tsutsui M, Noguchi S, Iha Y, Naito K, Ogoshi T, Nishida C, Tahara M, Yamashita H, Wang K-Y, Toyohira Y, Yanagihara N, Masuzaki H, Shimokawa H, Tanimoto A, Yatera K. Spontaneous pulmonary emphysema in mice lacking all three nitric oxide synthase isoforms. Sci Rep. (in press) (IF=4.379)

  6. Ishii J, Kashiwabara K, Ozaki Y, Takahashi H, Kitagawa F, Nishimura H, Ishii H, Iimuro S, Kawai H, Muramatsu T, Naruse H, Iwata H, Tanizawa-Motoyama S, Ito H, Watanabe E, Matsuyama Y, Fukumoto Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Hokimoto S, Miyauchi K, Ohashi Y, Ohtsu H, Izawa H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Matsuzaki M, Nagai R. Small dense low-density lipoprotein cholesterol and cardiovascular risk in statin-treated patients with coronary artery disease. J Atheroscler Thromb. (in press) (IF=4.928)

  7. Yokoyama Y, Miyamoto K, Nakai M, Sumita Y, Ueda N, Nakajima K, Kamakura T, Wada M, Yamagata K, Ishibashi K, Inoue Y, Nagase S, Noda T, Aiba T, Miyamoto Y, Yasuda S, Kusano K. Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROAD-DPC Study. J Am Heart Assoc. 2021 Jun;10(11):e019701. doi: 10.1161/JAHA.120.019701. (IF=5.501)

  8. Bairey Merz CNB, Beltrame JF, Berry C, Boden WE, Camici PG, Crea F, Hochman JS, Kaski JC, O'Gara PT, Ong P, Pepine CJ, Shimokawa H, Sechtem U, Stone GW. Insights to advance our management of myocardial ischemia: From obstructive epicardial disease to functional coronary alterations. Am Heart J Open. DOI: 10.1016/j.ahjo.2021.100060.

  9. Suzuki H, Takanami K, Takase K, Shimokawa H, Yasuda S. Reversible increase in stress-associated neurobiological activity in the acute phase of Takotsubo syndrome; a brain 18F-FDG-PET study. Int J Cardiol. DOI: 10.1016/j.ijcard.2021.09.057 (IF=4.164)

  10. Takahashi J, Suda A, Yasuda S, Shimokawa H. Measurement of myocardial lactate production for diagnosis of coronary microvascular spasm. J Vis Exp. (175), e62558, doi:10.3791/62558 (2021). (IF=1.355)

  11. Watanabe T, Matsumoto Y, Nishimiya K, Shindo T, Amamizu H, Sugisawa J, Tsuchiya S, Sato K, Morosawa S, Ohyama K, Watanabe-Asaka T, Hayashi M, Kawai Y, Takahashi J, Yasuda S, Shimokawa H. Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo. PLoS One 2021 Sep 13;16(9):e0257175. (IF=3.240)

  12. Veronese G, Ammirati E, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun OO, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foa A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias. Eur J Heart Fail. (in press) (IF=15.534)

  13. Abe M, Ozaki Y, Takahashi H, Ishii M, Masunaga N, Ismail TF, Iimuro S, Fujita R, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Ogawa H, Daida H, Shimokawa H, Saito Y, Matsuzaki M, Akao M, Kimura T, Nagai R. Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy. Am Heart J. (in press) (IF=4.749)

  14. Shimokawa H, Suda A, Takahashi J, Berry C, Camici PG, Crea F, Escaned J, Ford T, Yii E, Kaski JC, Kiyooka T, Mehta PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yasuda S, Beltrame JF, Merz CNB; the Coronary Vasomotor Disorders International Study (COVADIS) Group. Clinical characteristics and prognosis of patients with microvascular angina -An international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group- Eur Heart J. 2021;42:4592-4600. (IF=29.983)

  15. Anegawa E, Takahama H, Nishimura K, Onozuka D, Irie Y, Moriuchi K, Amano M, Okada A, Amaki M, Kanzaki H, Noguchi T, Kusano K, Yasuda S, Izumi C. Improvements of predictive power of B-type natriuretic peptide on admission by mathematically estimating its discharge levels in hospitalised patients with acute heart failure. Open Heart. 2021 May;8(1):e001603. doi: 10.1136/openhrt-2021-001603.

  16. Igarashi Y, Nochioka K, Sakata Y, Tamai T, Ohkouchi S, Irokawa T, Ogawa H, Hayashi H, Fujihashi T, Yamanaka S, Shiroto T, Miyata S, Hata J, Yamada S, Ninomiya T, Yasuda S, Kurosawa H, Shimokawa H. Risk prediction for new-onset atrial fibrillation using the Minnesota code electrocardiography classification system. Int J Cardiol Heart Vasc. 2021 Mar 31;34:100762. doi: 10.1016/j.ijcha.2021.100762. eCollection 2021 Jun.

  17. Atarashi H, Uchiyama S, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H. Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: Sub-analysis of the EXPAND Study. Heart Vessels. 36(9):1410-1420,2021. (IF=2.037)

  18. Ichijo S, Shindo T, Eguchi K, Monma Y, Nakata T, Morisue Y, Kanai H, Osumi N, Yasuda S, Shimokawa H. Low-intensity pulsed ultrasound therapy promotes recovery from stroke by enhancing angio-neurogenesis in mice in vivo. Sci Rep. 2021 Mar 2;11(1):4958. doi: 10.1038/s41598-021-84473-6. (IF=4.379)

  19. Kurosawa R, Satoh K, Nakata T, Shindo T, Kikuchi N, Satoh T, Siddique M, Omura J, Sunamura S, Nogi M, Takeuchi Y, Miyata S, Shimokawa H. Identification of celastrol as a therapeutic agent for pulmonary hypertension and right ventricular failure via suppression of basigin/cyclophilin A. Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1205-1217. doi: 10.1161/ATVBAHA.120.315731. (IF=8.311)

  20. Ikeda S, Nah J, Shirakabe A, Zhai P, Oka S, Sciarretta S, Guan K, Shimokawa H, Sadoshima J. YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases. J Clin Invest. 2021;131(5):e143173. DOI:10.1172/JCI143173 (IF=14.808)

  21. Doi T, Hori M, Harada-Shiba M, Kataoka Y, Onozuka D, Nishimura K, Nishikawa R, Tsuda K, Ogura M, Son C, Miyamoto Y, Noguchi T, Shimokawa H, Yasuda S. Patients with LDLR and PCSK9 gene variants experienced higher incidence of cardiovascular outcomes in heterozygous familial hypercholesterolemia. J Am Heart Assoc. 2021 https://doi.org/10.1161/JAHA.120.018263 (IF=5.501)

  22. Nishimiya K, Suda A, Fukui K, Hao K, Takahashi J, Matsumoto Y, Mitsuishi K, Watanabe T, Ohyama K, Sugisawa J, Tsuchiya S, Satoh K, Shindo T, Godo S, Kikuchi Y, Shiroto T, Yasuda S, Shimokawa H. Prognostic links between OCT-delineated coronary morphologies and coronary functional abnormalities in patients with INOCA. JACC Cardiovasc Interv. 14:606-618,2021. (IF=11.195)

  23. Miyagi T, Miyata S, Tagami S, Hiratsuka Y, Sato M, Takeda I, Kohata K, Satake N, Shimokawa H, Inoue A. Prognostic model for patients with advanced cancer using a combination of routine blood test values. Supportive Care in Cancer. 29:4431-4437,2021. (IF=3.603)

  24. Sugisawa J, Matsumoto Y, Takeuchi M, Suda A, Tsuchiya S, Ohyama K, Nishimiya K, Akizuki M, Sato K, Oura S, Ota H, Ikeda S, Shindo T, Kikuchi Y, Hao K, Shiroto T, Takahashi J, Miyata S, Sakata Y, Takase K, Kohzuki M, Shimokawa H. Beneficial effects of exercise training on physical performance in patients with vasospastic angina. Int J Cardiol. 328:14-21,2021. (IF=4.164)

  25. Omote K, Yokota I, Nagai T, Sakuma I, Nakagawa Y, Kamiya K, Iwata H, Miyauchi K, Ozaki Y, Hibi K, Hiro T, Fukumoto Y, Mori H, Hokimoto S, Ohashi Y, Ohtsu H, Ogawa H, Daida H, Iimuro S, Shimokawa H, Saito Y, Kimura T, Matsuzaki M, Nagai R, Anzai T, for the REAL-CAD study investigators. HDL and cardiovascular events in patients with stable coronary artery disease treated with statins: an observation from the REAL-CAD Study. J Atheroscler Thromb. 2021 Jan 9. doi: 10.5551/jat.59881 (IF=4.928)

  26. Hao K, Takahashi J, Kikuchi Y, Suda A, Sato K, Sugisawa J, Tsuchiya S, Shindo T, Nishimiya K, Ikeda S, Tsuburaya R, Shiroto T, Matsumoto Y, Miyata S, Sakata Y, Yasuda S, Shimokawa H. Prognostic impacts of comorbid significant coronary stenosis and coronary artery spasm in patients with stable coronary artery disease -Possible implications for the ISCHEMIA Trial- J Am Heart Assoc. 2021;10:e017831. https://doi.org/10.1161/JAHA.120.017831 (IF=5.501)

  27. Suda A, Takahashi J, Beltrame JF, Berry C, Camici PG, Crea F, Escaned J, Ford T, Kaski JC, Kiyooka T, Metha PK, Ong P, Ozaki Y, Pepine C, Rimoldi O, Safdar B, Sechtem U, Tsujita K, Yii E, Merz CNB, Shimokawa H. International prospective cohort study of microvascular angina -rationale and design- Int J Cardiol Heart Vasc. 2020 Sep 11;31:100630. doi: 10.1016/j.ijcha.2020.100630. eCollection 2020 Dec.

  28. Monma Y, Shindo T, Eguchi K, Kurosawa R, Kagaya Y, Ikumi Y, Ichijo S, Nakata T, Miyata S, Matsumoto A, Sato H, Miura M, Kanai H, Shimokawa H. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice -A possible novel therapy for HFpEF- Cardiovasc Res. 117:1325-1338,2021. (IF=10.787)

  29. Aoki T, Sugimura K, Terui Y, Tatebe S, Fukui S, Miura M, Yamamoto S, Yaoita N, Suzuki H, Sato H, Kozu K, Konno R, Miyata S, Nochioka K, Satoh K, MD, Shimokawa H. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - A randomized controlled study. Int J Cardiol Heart Vasc. (in press)

  30. Fukasawa K, Fukuda K, Mori N, Kondo M, Chiba T, Miki K, Hasebe Y, Nakano M, Shimokawa H. Impacts of sinus rhythm maintenance with catheter ablation on exercise tolerance in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol. (in press) (IF=1.900)

  31. Fujihashi T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Yamanaka S, Hayashi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H. Prognostic impacts of serum uric acid levels in patients with chronic heart failure -Insights from the CHART-2 Study- ESC Heart Failure. 2021;8:1027-1038. (IF=4.411)

  32. Suda A, Seitz A, Odaka Y, Athanasiadis A, Pirozzolo G, Sato K, Hao K, Bekeredjian R, Takahashi J, Sechtem U, Shimokawa H, Ong P. Assessment of coronary vasomotor responses to acetylcholine in German and Japanese patients with epicardial coronary spasm-more similarities than differences? Heart Vessels. 36:337-344,2021. (IF=2.037)

  33. Marume K, Noguchi T, Kamakura T, Tateishi E, Morita Y, Miura H, Nakaoku Y, Nishimura K, Yamada N, Tsujita K, Izumi C, Kusano K, Ogawa H, Yasuda S. Prognostic impact of multiple fragmented QRS on cardiac events in idiopathic dilated cardiomyopathy. Europace. 2021 Feb 5;23(2):287-297. doi: 10.1093/europace/euaa193. (IF=5.214)

  34. Lee SH, Kim HK, Jeong MH, Yasuda S, Honda S, Jeong YH, Lee JM, Hahn JY, Kang J, Chae SC, Seong IW, Park JS, Chae JK, Hur SH, Cha KS, Kim HS, Seung KB, Rha SW, Hwang JY, Choi DJ, Oh SK, Kim SS, Park TK, Yang JH, Song YB, Choi SH, Gwon HC; KAMIR, JAMIR, and SMART-DATE Investigators. Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):112-124. doi: 10.1093/ehjcvp/pvaa005. (IF=6.617)

  35. Tern PJW, Ho AKH, Sultana R, Ahn Y, Almahmeed W, Brieger D, Chew DP, Fong AYY, Hwang J, Kim Y, Komuro I, Maemura K, Mohd-Ali R, Quek DKL, Reid C, Tan JWC, Wan-Ahmad WA, Yasuda S, Yeo KK. Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):6-17. doi: 10.1093/ehjqcco/qcaa057. (IF=4.370)

  36. Okamoto C, Okada A, Nishimura K, Moriuchi K, Amano M, Takahama H, Amaki M, Hasegawa T, Kanzaki H, Fujita T, Kobayashi J, Yasuda S, Izumi C. Prognostic comparison of atrial and ventricular functional mitral regurgitation. Open Heart. 2021 Feb;8(1):e001574. doi: 10.1136/openhrt-2021-001574.

  37. Nakai M, Iwanaga Y, Sumita Y, Kanaoka K, Kawakami R, Ishii M, Uchida K, Nagano N, Nakayama T, Nishimura K, Tsuchihashi K, Kimura K, Saito Y, Tsujita K, Ogawa H, Miyamoto Y, Yasuda S; on the behalf of the JROAD Investigators. Validation of Acute Myocardial Infarction and Heart Failure Diagnoses in Hospitalized Patients With the Nationwide Claim-Based JROAD-DPC Database. Circ Rep. 2021 Feb 20;3(3):131-136. doi: 10.1253/circrep.CR-21-0004.

  38. Pocock S, Brieger DB, Owen R, Chen J, Cohen MG, Goodman S, Granger CB, Nicolau JC, Simon T, Westermann D, Yasuda S, Hedman K, Mellström C, Andersson Sundell K, Grieve R. Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis. Open Heart. 2021 Feb;8(1):e001499. doi: 10.1136/openhrt-2020-001499.

  39. Kitahara S, Kataoka Y, Miura H, Nishii T, Nishimura K, Murai K, Iwai T, Nakamura H, Hosoda H, Matama H, Doi T, Nakashima T, Honda S, Fujino M, Nakao K, Yoneda S, Nishihira K, Kanaya T, Otsuka F, Asaumi Y, Tsujita K, Noguchi T, Yasuda S. The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis. Atherosclerosis. 2021 Feb 24;322:1-7. doi: 10.1016/j.atherosclerosis.2021.02.019. Online ahead of print. (IF=5.162)

  40. Akao M, Yasuda S, Kaikita K, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H. Rivaroxaban Monotherapy versus Combination Therapy According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation and Stable Coronary Disease: AFIRE trial sub-analysis. Am Heart J. 2021 Feb 28:S0002-8703(21)00063-6. doi: 10.1016/j.ahj.2021.02.021. Online ahead of print. (IF=4.749)

  41. Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, Suzuki M, Kosuge M, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S; JAMIR Investigators. Characteristics and clinical outcomes of patients with de-escalation from prasugrel to clopidogrel after acute myocardial infarction - Insights from the prospective Japan Acute Myocardial Infarction Registry (JAMIR). J Cardiol. 2021 Mar 18:S0914-5087(21)00055-1. doi: 10.1016/j.jjcc.2021.03.001. Online ahead of print. (IF=3.159)

  42. Sugane H, Kataoka Y, Otsuka F, Nakaoku Y, Nishimura K, Nakano H, Murai K, Honda S, Hosoda H, Matama H, Doi T, Nakashima T, Fujino M, Nakao K, Yoneda S, Tahara Y, Asaumi Y, Noguchi T, Kawai K, Yasuda S. Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule. Atherosclerosis. 2021 Feb;318:70-75. doi: 10.1016/j.atherosclerosis.2020.11.005. Epub 2020 Nov 11. (IF=5.162)

  43. Sawada K, Kawakami S, Murata S, Nishimura K, Tahara Y, Hosoda H, Nakashima T, Kataoka Y, Asaumi Y, Noguchi T, Sugimachi M, Fujita T, Kobayashi J, Yasuda S. Predicting Parameters for Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock. ESC Heart Fail. 2021 Feb;8(1):471-480. doi: 10.1002/ehf2.13097. Epub 2020 Dec 2. (IF=4.411)

  44. Yokouchi-Konishi T, Kamiya CA, Shionoiri T, Nakanishi A, Iwanaga N, Izumi C, Yasuda S, Yoshimatsu J. Pregnancy outcomes in women with dilated cardiomyopathy: Peripartum cardiovascular events predict post delivery prognosis. J Cardiol. 2021 Mar;77(3):217-223. doi: 10.1016/j.jjcc.2020.07.007. Epub 2020 Jul 30. (IF=3.159)

  45. Kim HK, Tantry US, Smith SC Jr, Jeong MH, Park SJ, Kim MH, Lim DS, Shin ES, Park DW, Huo Y, Chen SL, Bo Z, Goto S, Kimura T, Yasuda S, Chen WJ, Chan M, Aradi D, Geisler T, Gorog DA, Sibbing D, Lip GYH, Angiolillo DJ, Gurbel PA, Jeong YH. The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. Thromb Haemost. 2021 Apr;121(4):422-432. doi: 10.1055/s-0040-1718729. Epub 2020 Nov 10. (IF=5.249)

  46. Kuyama N, Hamatani Y, Okada A, Irie Y, Nakai M, Takahama H, Yanagi Y, Jo Y, Kanzaki H, Yasuda S, Tsujita K, Izumi C. Comparison of Clinical Characteristics, Natural History and Predictors of Disease Progression in Patients With Degenerative Mitral Stenosis Versus Rheumatic Mitral Stenosis. Am J Cardiol. 2021 Mar 15;143:118-124. doi: 10.1016/j.amjcard.2020.12.026. Epub 2020 Dec 31. (IF=2.778)